Cargando...
AB041. P-09. Neoadjuvant chemotherapy with portal vein embolization for initially unresectable hilar cholangiocarcinoma—a case report
BACKGROUND: Hilar cholangiocarcinoma accounts for 60% of cholangiocarcinomas from an anatomic point of view, followed by 30% of extrahepatic and 10% of intrahepatic. Curative resection represents the only hope for cure; however, more than 60% patients diagnosed of hilar cholangiocarcinoma were deeme...
Guardado en:
| Publicado en: | Hepatobiliary Surg Nutr |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AME Publishing Company
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421192/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2019.AB041 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|